Surgical treatment of Crohn's disease: the risk of complications
https://doi.org/10.38181/2223-2427-2023-1-4
Abstract
Aim: assessment of the impact of biological therapy on risk factors for postoperative complications. Materials and methods: the study included 116 patients operated on for Crohn's disease. The mean age of the patients was 38.2 years, among them 65 men (56 %) and 51 women (44 %). The influence of various factors on complications in the postoperative period was analyzed using the IBM-SPSS software for Mac version 22.0 and Microsoft Excel 1997-2003. Results: 32.7 % of the patients received biological therapy, and postoperative complications developed in 31 % of the operated patients. There was no association between receiving biological therapy and the risk of postoperative complications. The risk factor was the formation of a stoma and surgery for emergency indications. Conclusion: an important task before surgical treatment for Crohn's disease is a thorough preoperative preparation and assessment of all risk factors for complications of surgical intervention by a multidisciplinary team.
About the Authors
M. A. Danilov
Loginov Moscow Clinical Scientific Centre
Russian Federation
Russian Federation
Mikhail A. Danilov - Head of the Department of Coloproctology, Loginov Moscow Clinical Scientific Centre.
Shosse Entuziastov 86, Moscow, 111123
A. V. Leontyev
Loginov Moscow Clinical Scientific Centre
Russian Federation
Russian Federation
Aleksandr V. Leontyev - Coloproctologist, Loginov Moscow Clinical Scientific Centre.
Shosse Entuziastov 86, Moscow, 111123
A. B. Baichorov
Loginov Moscow Clinical Scientific Centre
Russian Federation
Russian Federation
Aslan B. Baichorov - Coloproctologist, Loginov Moscow Clinical Scientific Centre.
Shosse Entuziastov 86, Moscow, 111123
Z. M. Abdulatipova
Loginov Moscow Clinical Scientific Centre
Russian Federation
Russian Federation
Zaira M. Abdulatipova - Coloproctologist, Loginov Moscow Clinical Scientific Centre.
Shosse Entuziastov 86, Moscow, 111123
G. G. Saakyan
Loginov Moscow Clinical Scientific Centre
Russian Federation
Russian Federation
Georgiy G. Saakyan - Coloproctologist, Loginov Moscow Clinical Scientific Centre.
Shosse Entuziastov 86, Moscow, 111123
A. A. Demidova
Loginov Moscow Clinical Scientific Centre
Russian Federation
Russian Federation
Anastasiya A. Demidova - PhD student, Department of Coloproctology, Loginov Moscow Clinical Scientific Centre.
Shosse Entuziastov 86, Moscow, 111123
References
1. Sakurai Kimura CM, Scanavini Neto A, Queiroz NSF, Horvat N, Camargo MGM, Borba MR, Sobrado CW, Cecconello I, Nahas SC. Abdominal Surgery in Crohn's Disease: Risk Factors for Complications. Inflamm Intest Dis. 2021. Feb 6(1):18—24. https://doi.org/10.1159/000510999.
2. Oresland T, Faerden AE. Surgery in the age of biological treatment. Scand J Gastroenterol. 2015. Jan 50(1):121—127. https://doi.org/10.3109/00365521.2014.972445.
3. Wong DJ, Roth EM, Feuerstein JD, Poylin VY. Surgery in the age of biologics. Gastroenterol Rep (Oxf). 2019. Apr 7(2):77—90. https://doi.org/10.1093/gastro/goz004.
4. Kirchhoff P, Clavien PA, Hahnloser D. Complications in colorectal surgery: risk factors and preventive strategies. Patient Saf Surg. 2010. Mar 25;4(1):5. https://doi.org/10.1186/1754-9493-4-5.
5. Bossuyt P, Debeuckelaere C, Ferrante M, Vanbeckevoort D, Billiet T, Wolthuis A, van Assche G, D'Hoore A, Vermeire S. The operative risk and natural history after the diagnosis of ileal penetrating Crohn's disease. Eur J Gastroenterol Hepatol. 2018. May 30(5):539—545. https://doi.org/10.1097/MEG.0000000000001091.
6. Galliamov EA, Agapov MA, Lutsevich O, Kubyshkin VA, Kakotkin VV, Tolstykh MP. Early ileostomy closure in patients with rectal cancer. Primary results of the randomized controlled multicenter trial. Pirogov Russian Journal of Surgery = Khirurgiya. Zurnal im. N. I. Pirogova. 2019;(6):35—40 (in Russ., in Engl.). https://doi. org/10.17116/hirurgia201906135.
7. Hyman NH, Cheifetz AS. PUCCINI: Safety of Anti-TNF in the Perioperative Setting. Gastroenterology. 2022. Jul 163(1):44—46. https://doi.org/10.1053/j.gastro.2022.04.050.
8. Lightner AL, McKenna NP, Alsughayer A, Harmsen WS, Taparra K, Parker ME, Raffals LE, Loftus EV Jr. Biologics and 30-Day Postoperative Complications After Abdominal Operations for Crohn's Disease: Are There Differences in the Safety Profiles? Dis Colon Rectum. 2019. Nov 62(11):1352—1362. https://doi.org/10.1097/DCR.0000000000001482.
9. Peyrin-Biroulet L, Salleron J, Filippi J, Reenaers C, Antunes O, Filipe V, Louis E, Hebuterne X, Roblin X. Anti-TNF Monotherapy for Crohn's Disease: a 13-year Multicentre Experience. J Crohns Colitis. 2016. May 10(5):516—524. https://doi.org/10.1093/ecco-jcc/jjw008.
10. Abdalla S, Brouquet A, Maggiori L, Zerbib P, Denost Q, Germain A, Cotte E, Beyer-Berjot L, Munoz-Bongrand N, Desfourneaux V, Rahili A, Duffas JP, Pautrat K, Denet C, Bridoux V, Meurette G, Faucheron JL, Loriau J, Guillon F, Vicaut E, Benoist S, Panis Y, Lefevre JH. Postoperative Morbidity After Iterative Ileocolonic Resection for Crohn's Disease: Should we be Worried? A Prospective Multicentric Cohort Study of the GETAID Chirurgie. J Crohns Colitis. 2019. Dec 10;13(12):1510—1517. https://doi.org/10.1093/ecco-jcc/jjz091.
11. Huang W, Tang Y, Nong L, Sun Y. Risk factors for postoperative intra-abdominal septic complications after surgery in Crohn's disease: A meta-analysis of observational studies. J Crohns Colitis. 2015. Mar 9(3):293—301. https://doi.org/10.1093/ecco-jcc/jju028.
12. Luong TV, Grandt SD, Negoi I, Palubinskas S, El-Hussuna A. Preoperative factors associated with prolonged postoperative in-hospital length of stay in patients with Crohn's disease undergoing intestinal resection or strictureplasty. Int J Colorectal Dis. 2019. Nov 34(11):1925—1931. https://doi.org/10.1007/s00384-019-03418-8.
13. Shental O, Tulchinsky H, Greenberg R, Klausner JM, Avital S. Positive histological inflammatory margins are associated with increased risk for intra-abdominal septic complications in patients undergoing ileocolic resection for Crohn's disease. Dis Colon Rectum. 2012. Nov 55(11):1125—1130. https://doi.org/10.1097/DCR.0b013e318267c74c.
14. Yoon YS, Stocchi L, Holubar S, Aiello A, Shawki S, Gorgun E, Steele SR, Delaney CP, Hull T. When should we add a diverting loop ileostomy to laparoscopic ileocolic resection for primary Crohn's disease? Surg Endosc. 2021. Jun 35(6):2543—2557. https://doi.org/10.1007/s00464-020-07670-w.
15. Ghoneima AS, Flashman K, Dawe V, Baldwin E, Celentano V. High risk of septic complications following surgery for Crohn's disease in patients with preoperative anaemia, hypoalbuminemia and high CRP. Int J Colorectal Dis. 2019. Dec 34(12):2185—2188. https://doi.org/10.1007/s00384-019-03427-7.
16. Tiberi A, Pesi B, Giudici F, Zambonin D, Nelli T, Cupellini C, Ficari F, Cianchi F, Scaringi S. Laparoscopic 50 ileo-colic resection and right hemicolectomy for Crohn's disease and colon cancer: a preliminary comparative study on post-operative outcome. Updates Surg. 2020. Sep 72(3):821—826. https://doi.org/10.1007/s13304-020-00769-8.
Review
For citations:
Danilov M.A., Leontyev A.V., Baichorov A.B., Abdulatipova Z.M., Saakyan G.G., Demidova A.A. Surgical treatment of Crohn's disease: the risk of complications. Surgical practice (Russia). 2023;(1):42-52. (In Russ.) https://doi.org/10.38181/2223-2427-2023-1-4
Views:
614
Email this article 